Healing Realty Trust add to its board of directors

Shant Banosian and Jared Chupaila join the board to expand HRT's global presence

Healing Realty Trust (HRT), a real estate investment company focused on acquiring healthcare-related assets, announced that it has further bolstered its board of directors.

HRT, formerly known as Healing Commercial Real Estate Inc., have appointed Shant Banosian, a mortgage loan officer who was first in the business to surpass one billion dollars in home loan sales. 

Shant's expertise in mortgage lending complements the board's existing backing of leaders across the real estate, finance, capital markets, and healthcare industries.

Shant is currently the Executive Vice President of Sales at Guaranteed Rate, a mortgage lending and digital financial services firm, where he has solidified his position as the company's number one Loan Officer for eight years running. 

"Shant is a powerhouse in the mortgage lending space and has proven his expertise to be a covetable resource in the real estate industry," said Joe Caltabiano, Chief Executive Officer of HRT. 

"The breadth of Shant's achievements is a strong testament to his unparalleled dedication to serving both his clients and communities. The knowledge he provides will be incredibly valuable as we strengthen our corporate governance structure in anticipation of several growth opportunities that will shape the future of HRT."

Earlier this month, the Company also appointed former CEO of Brookfield Properties retail real estate vertical, Jared Chupaila, to the Board, bringing the total number of members to seven, following the departure of Nathan Cali. Joe Caltabiano concluded, "On behalf of myself and the team, I would like to thank Nathan for his valued contributions and strong dedication to HRT's vision since its inception."

HRT is a data-driven company that intends to acquire NNN-leased healthcare-related real estate assets, managing both property acquisition and interior buildout to optimise the properties for each tenant or practitioner. 

With escalating healthcare costs driving patients to explore novel treatments and an overall growing prioritisation of wellness across the U.S., the behavioural health market is projected to be valued at $132.4 billion by 2027.

You may also like